Watch CCEL. Know when insiders buy.
One email the day a filing lands. Free.
CCEL
CRYO CELL INTERNATIONAL INC
4.11
−0.15 −3.52%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $33.1MP/E —DIV YIELD —FCF YIELD 18.44%REV TTM —NET INCOME −$2.5MNET DEBT $7.8M52W 2.89 – 4.93SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · May 31 | — | — | — | $1.2M | $555K | +55.9% | 0.07 | $1.8M | $33K | $1.8M | Jul 15 |
| Q1 2026 · Feb 28 | — | — | — | $765K | $47K | −83.3% | 0.01 | $652K | $67K | $585K | Apr 14 |
| Q4 2025 · Nov 30derived | — | — | — | −$4M | −$3.8M | — | -0.47 | $1.3M | $67K | $1.2M | Feb 27 |
| Q3 2025 · Aug 31 | — | — | — | $1.9M | $749K | −28.7% | 0.09 | $2.5M | $39K | $2.5M | Oct 15 |
| Q2 2025 · May 31 | — | — | — | $1.5M | $356K | −45.7% | 0.04 | $707K | $62K | $645K | Jul 15 |
| Q1 2025 · Feb 28 | — | — | — | $1.1M | $283K | −49.1% | 0.03 | $954K | $62K | $892K | Apr 14 |
| Q4 2024 · Nov 30derived | — | — | — | −$122K | −$1.9M | — | -0.22 | $2.2M | $8K | $2.1M | Feb 27 |
| Q3 2024 · Aug 31 | — | — | — | $1.4M | $1.1M | +54.5% | 0.13 | $2.4M | $186K | $2.3M | Oct 15 |
| Q2 2024 · May 31 | — | — | — | $1.4M | $656K | — | 0.08 | $1.8M | $1.8M | $22K | Jul 15 |
| Q1 2024 · Feb 29 | — | — | — | $821K | $556K | — | 0.07 | −$357K | $458K | −$815K | Apr 14 |
| Q4 2023 · Nov 30derived | — | — | — | −$16.2M | −$11.2M | — | -1.34 | $3.3M | $1.7M | $1.6M | Feb 28 |
| Q3 2023 · Aug 31 | — | — | — | $1.2M | $681K | — | 0.08 | $1.9M | $3.3M | −$1.3M | Oct 15 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Nov 30 | — | — | $482K | −$2.4M | — | -0.30 | $5.5M | $230K | $5.2M | $170K | $3.2M |
| FY2024 · to Nov 30 | — | — | $3.5M | $402K | — | 0.05 | $6M | $2.4M | $3.6M | $1.4M | $2M |
| FY2023 · to Nov 30 | — | — | −$12.3M | −$9.5M | — | -1.14 | $8.9M | $6.8M | $2.1M | $799K | $0 |
| FY2022 · to Nov 30 | — | — | $4M | $2.8M | — | 0.33 | $8.6M | $12.2M | −$3.6M | $1.8M | $7.7M |
| FY2021 · to Nov 30 | — | — | $4M | $2.1M | — | 0.25 | $7.9M | $1.8M | $6.1M | $249K | $0 |
| FY2020 · to Nov 30 | — | — | $7.7M | $3.6M | — | 0.45 | $8.5M | $100K | $8.4M | — | — |
Every number comes from CRYO CELL INTERNATIONAL INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.